1. Public health value of universal HPV vaccination
Riccardo A. Audisio, Giancarlo Icardi, Andrea M. Isidori, Carlo A. Liverani, Alberto Lombardi, Luciano Mariani, Francesco Saverio Mennini, David A. Mitchell, Andrea Peracino, Sergio Pecorelli, Giovanni Rezza, Carlo Signorelli, Giovanni Vitali Rosati, Gian Vincenzo Zuccotti 
Critical Reviews in Oncology / Hematology 
Volume 97, Pages (January 2016)
DOI: /j.critrevonc
Copyright © Terms and Conditions

2. Fig. 1
Estimate of the reduction of the remaining HPV-16,-18-genital and anal cancers burden in females in Europe through female-only HPV vaccination and universal HPV vaccination (age 12 years, 70% VCR).
Critical Reviews in Oncology / Hematology  , DOI: ( /j.critrevonc )
Copyright © Terms and Conditions

3. Fig. 2
Reduction of the remaining HPV-16,-18-anal cancer burden in females and males in Europe through female-only HPV vaccination and universal HPV vaccination (age 12 years, 70% VCR).
Critical Reviews in Oncology / Hematology  , DOI: ( /j.critrevonc )
Copyright © Terms and Conditions

4. Fig. 3
Reduction of the remaining HPV-6,-11-genital warts burden in females and males in Europe through female-only vaccination and universal vaccination (excluding HPV-related head/neck cancers) (age 12 years, 70% VCR).
Critical Reviews in Oncology / Hematology  , DOI: ( /j.critrevonc )
Copyright © Terms and Conditions